Literature DB >> 20490570

[Postoperative multimodal pain management : Cost-minimisation analysis from a hospital's point of view].

A Bernschein1, M Redaèlli, S Stock.   

Abstract

BACKGROUND: Adequate pain management after major surgery is important to improve patients' quality of life and to support the healing process. Since the cost for pain management is included in the DRG system for hospital reimbursement, hospitals should aim to provide adequate postoperative pain management at the lowest possible cost. In this study we compare two multimodal pain management schemes for postoperative pain management in a cost-minimisation analysis.
METHODS: In a decision analytic model two treatment regimes for postoperative pain management are compared in a cost-minimisation analysis: diclofenac + morphine vs paracetamol vs morphine. The study is performed from the perspective of a public hospital. Due to the short time horizon costs are not discounted.
RESULTS: Assuming comparable effectiveness for adequate postoperative pain management, the expected value in the decision tree model for the combination diclofenac + morphine is 13.37 EUR and for the combination paracetamol + morphine 32.23 EUR, respectively. The results are robust under various one- and two-way sensitivity analyses.
CONCLUSION: With no contraindications given the combination diclofenac + morphine is more cost-effective for postoperative pain management after major surgery compared to paracetamol + morphine.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20490570     DOI: 10.1007/s00482-010-0930-2

Source DB:  PubMed          Journal:  Schmerz        ISSN: 0932-433X            Impact factor:   1.107


  31 in total

Review 1.  Effect of postoperative analgesia on surgical outcome.

Authors:  H Kehlet; K Holte
Journal:  Br J Anaesth       Date:  2001-07       Impact factor: 9.166

Review 2.  Cancer pain relief and palliative care. Report of a WHO Expert Committee.

Authors: 
Journal:  World Health Organ Tech Rep Ser       Date:  1990

3.  Does multimodal analgesia with acetaminophen, nonsteroidal antiinflammatory drugs, or selective cyclooxygenase-2 inhibitors and patient-controlled analgesia morphine offer advantages over morphine alone? Meta-analyses of randomized trials.

Authors:  Nadia Elia; Christopher Lysakowski; Martin R Tramèr
Journal:  Anesthesiology       Date:  2005-12       Impact factor: 7.892

4.  Psychological influences on surgical recovery. Perspectives from psychoneuroimmunology.

Authors:  J K Kiecolt-Glaser; G G Page; P T Marucha; R C MacCallum; R Glaser
Journal:  Am Psychol       Date:  1998-11

5.  Comparison between patient-controlled analgesia and subcutaneous morphine in elderly patients after total hip replacement.

Authors:  H Keïta; N Geachan; S Dahmani; E Couderc; C Armand; M Quazza; J Mantz; J M Desmonts
Journal:  Br J Anaesth       Date:  2003-01       Impact factor: 9.166

6.  Analgesic efficacy and safety of nefopam vs. propacetamol following hepatic resection.

Authors:  O Mimoz; P Incagnoli; C Josse; M C Gillon; L Kuhlman; A Mirand; H Soilleux; D Fletcher
Journal:  Anaesthesia       Date:  2001-06       Impact factor: 6.955

Review 7.  Epidural anesthesia and analgesia. Their role in postoperative outcome.

Authors:  S Liu; R L Carpenter; J M Neal
Journal:  Anesthesiology       Date:  1995-06       Impact factor: 7.892

8.  Adjunctive analgesia with intravenous propacetamol does not reduce morphine-related adverse effects.

Authors:  F Aubrun; F Kalfon; P Mottet; A Bellanger; O Langeron; P Coriat; B Riou
Journal:  Br J Anaesth       Date:  2003-03       Impact factor: 9.166

9.  Analgesic effect of acetaminophen in humans: first evidence of a central serotonergic mechanism.

Authors:  Gisèle Pickering; Marie-Anne Loriot; Frédéric Libert; Alain Eschalier; Philippe Beaune; Claude Dubray
Journal:  Clin Pharmacol Ther       Date:  2006-04       Impact factor: 6.875

10.  Randomized, double-blind, placebo-controlled study of the effect of rectal paracetamol on morphine consumption after abdominal hysterectomy.

Authors:  O Kvalsvik; P C Borchgrevink; L Hagen; O Dale
Journal:  Acta Anaesthesiol Scand       Date:  2003-04       Impact factor: 2.105

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.